Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 396-402

  Guo, Zhongying ^a   Chen, Li ^a   Zhu, Yuanyuan ^b   Zhang, Yixin ^c   He, Song ^c   Qin, Jin ^a   Tang, Xiaojun ^b   Zhou, Jiaming ^a   Wei, Yingze ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

^c Biomics Biotechnologies Co Ltd   (China)

Author keywords

Angiogenesis; Apoptosis; Double stranded RNA; Human hepatocellular carcinoma; Toll like receptor 3

Indexed keywords

BM 06; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MESSENGER RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MIGRATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HEP G2 CELLS; HUMANS; LIGANDS; LIVER NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; RATS; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3;

EID: 84862912428     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1538     Document Type: Article

References (32)

1. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738, 2001. (Pubitemid 33009951)
2. Choe J, Kelker MS and Wilson IA: Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585, 2005. (Pubitemid 41033635)
3. Leonard JN, Ghirlando R, Askins J, et al: The TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl Acad Sci USA 105: 258-263, 2008.
4. Takada E, Okahira S, Sasai M, Funami K, Seya T and Matsumoto M: C-terminal LRRRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Mol Immunol 44: 3633-3640, 2007.
5. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S and Sen GC: Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11: 1060-1067, 2004.
6. Cho WG, Albuquerque RJ, Kleinman ME, et al: Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci USA 106: 7137-7142, 2009.
7. Kleinman ME, Yamada K, Takeda A, et al: Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597, 2008. (Pubitemid 351483358)
8. Paone A, Galli R, Gabellini C, et al: Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. Neoplasia 12: 539-549, 2010.
9. Salaun B, Coste I, Rissoan MC, Lebecque SJ and Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176: 4894-4901, 2006.
10. Kaiser WJ, Kaufman JL and Offermann MK: IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 172: 1699-1710, 2004. (Pubitemid 38116818)
11. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
12. Abe R, Fujita Y and Yamagishi S: Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma. Mini Rev Med Chem 7: 649-661, 2007. (Pubitemid 47099184)
13. Dudek A, Gupta K, Ramakrishnan S and Mukhopadhyay D: Tumor angiogenesis. J Oncol: Sep 19, 2010 (Epub ahead of print).
14. Song E, Zhu P, Lee SK, et al: Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23: 709-717, 2005.
15. Saleh MC, van Rij RP, Hekele A, et al: The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat Cell Biol 8: 793-802, 2006.
16. Soutschek J, Akinc A, Bramlage B, et al: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178, 2004.
17. de Fougerolles A, Vornlocher HP, Maraganore J and Lieberman J: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6: 443-453, 2007. (Pubitemid 47064567)
18. Dogusan Z, Garcia M, Flamez D, et al: Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 57: 1236-1245, 2008.
19. Yeh TC, Chiang PC, Li TK, et al: Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 73: 782-792, 2007.
20. Paone A, Starace D, Galli R, et al: Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis 29: 1334-1342, 2008.
21. Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13: 4565-4574, 2007.
22. Matijevic T, Marjanovic M and Pavelic J: Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol 70: 18-24, 2009.
23. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
24. Pollman MJ, Naumovski L and Gibbons GH: Endothelial cell apoptosis in capillary network remodeling. J Cell Physiol 178: 359-370, 1999.
25. Xin X, Yang S, Ingle G, et al: Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158: 1111-1120, 2001.
26. Nicosia RF, Lin YJ, Hazelton D and Qian X: Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am J Pathol 151: 1379-1386, 1997. (Pubitemid 27479768)
27. Jiang Q, Wei H and Tian Z: Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. Bmcmc Cancer 8: 12, 2008.
28. Nomi N, Kodama S and Suzuki M: Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. Oncol Rep 24: 225-231, 2010.
29. Rasschaert J, Ladriere L, Urbain M, et al: Toll-like receptor 3 and STSTAT-1 contribute to double-stranded RNA + interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J Biol Chem 280: 33984-33991, 2005.
30. Sato A, Iizuka M, Nakagomi O, et al: Rotavirus double-stranded RNA induces apoptosis and diminishes wound repair in rat intestinal epithelial cells. J Gastroenterol Hepatol 21: 521-530, 2006.
31. El-Serag HB, Marrero JA, Rudolph L and Reddy KR: Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-1763, 2008.
32. Lacour J, Laplanche A, Delozier T, et al: Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.). Breast Cancer Res Treat 19: 15-21, 1991.